Addex Therapeutics : about addex

Search Preview

www.addextherapeutics.com/

Most Used Html Elements

<div> : 376
<p> : 326
<a> : 126
<span> : 73
<br> : 69
<strong> : 56
<link> : 14
<li> : 13
<td> : 9
<script> : 9
<ul> : 6
<meta> : 4
<tr> : 2
<input> : 2
<table> : 2
<img> : 2

Most Used Html Classes

"block" : 109
"news-home" : 105
"news_title" : 105
"news_list_item" : 105
"align-justify" : 66
"box" : 8
"at15nc" : 5
"hs1" : 5
"at300bs" : 5
"separator" : 4
"at300b" : 4
"msonormal" : 3
"container_16" : 3
"hs4" : 3
"first" : 3
"clear" : 3
"indent" : 3
"grid_16" : 2
"zone" : 2
"last" : 2
"grid_4" : 2

Where is www.addextherapeutics.com hosted?

Country:

Switzerland

Registrar:

GoDaddy.com, LLC

Latitude:

47.14

Longitude:

8.16

IP address:

83.166.136.50

IP Binary address:

1010011101001101000100000110010

IP Octal address:

12351504062

IP Hexadecimal address:

53a68832

Context analysis of addextherapeutics.com

Number of letters on this page:

4 925

Number of words on this page:

880

Number of sentences on this page:

53

Average words per sentences on this page:

17

Number of syllables on this page:

1 730

Number of Strong texts:

39

Domain name architecture

Domain name length:

21

Hyphens:

Domain doesn't contain hyphens!

Domain name with Hindi letters:

अ द द ए ख़ ट (h) ए र अ प ए उ ट इ च स . च ओ म

Domain name with Hebrew letters:

(a) ד ד (e) כס ת ה (e) ר (a) פּ (e) (u) ת (i) ק(c) שׂ . ק(c) (ο) מ

Domain name with Cyrillic letters:

a д д e ξ т х e р a п e у т и ц с . ц о м

Domain name with Arabic letters:

ا د د (e) (x) ت ح (e) ر ا (p) (e) (u) ت (i) (c) ص . (c) (o) م

Domain name with Greek letters:

α δ δ ε ξ τ (h) ε ρ α π ε υ τ ι χ σ . χ ο μ

Domain name with Chinese letters:

诶迪迪伊艾克斯提艾尺伊艾儿诶屁伊伊吾提艾西艾丝 . 西哦艾马

Domain without Consonants:

ddxthrptcs.cm

Domain without Vowels:

aexeaeui.o

Alphabet positions:

a¹ d⁴ d⁴ e⁵ x²⁴ t²⁰ h⁸ e⁵ r¹⁸ a¹ p¹⁶ e⁵ u²¹ t²⁰ i⁹ c³ s¹⁹ . c³ o¹⁵ m¹³

Domain name pattern:
V: Vowel, C: Consonant, N: Number

V C C V C C C V C V C V V C V C C . C V C

<HEAD> DATA INFORMATION

Encoding:

utf-8

generator:

TYPO3 4.5 CMS

robots:

INDEX, FOLLOW

google-site-verification:

phIkT0Tvyy7BxDS3uvYcFTiNldeO7b8WJiJ8AB2YWvE

External links in addextherapeutics.com

http://www.youtube.com/watch?v=bwg7W7sJdHI

Internal links in addextherapeutics.com

/about/about-addex/
#
/rd/allostery-platform/
/investors/stock-data/
/careers/career-opportunities/
/about/executive-management/
/about/board-of-directors/
/about/about-addex/addex-history/
/fileadmin/user_upload/download/30092016-Condensed_ConsoInterimFSHY2016.pdf
/fileadmin/user_upload/AGM/2017_AGM/Addex_Einladung_GV_e_2017.pdf
/fileadmin/user_upload/Annual_Report/Report_2016/ADXN_Annual_Report_2016.pdf
/investors/press-releases/news-details/article/addex-shareholders-approved-all-board-proposals-at-2017-annual-general-meeting/
/investors/press-releases/news-details/article/addex-annual-general-meeting-scheduled-for-22-june-2017/
/investors/press-releases/news-details/article/addex-increases-issued-share-capital-and-creates-treasury-shares-1/
/investors/press-releases/news-details/article/addex-adx71441-demonstrates-preclinical-analgesic-effects/
/investors/press-releases/news-details/article/addex-adx71441-preclinical-results-for-treatment-of-alcohol-use-disorder-published-in-journal-of-psy/
/investors/press-releases/news-details/article/addex-therapeutics-provides-corporate-update-and-reports-2016-financial-results/
/investors/press-releases/news-details/article/addex-raises-chf30-million-through-private-placement-of-treasury-shares-and-extends-cash-runway-thr/
/investors/press-releases/news-details/article/addexs-adx71149-anti-epileptic-effect-highlighted-in-scientific-journal-epilepsia/
/investors/press-releases/news-details/article/addexs-clinical-programs-and-discovery-platform-highlighted-in-review-of-allosteric-modulators-fo/
/investors/press-releases/news-details/article/addex-awarded-835000-grant-from-michael-j-fox-foundation-to-advance-trkb-pams-for-the-treatment-o/
/investors/press-releases/news-details/article/addex-adx71441-demonstrates-statistically-significant-efficacy-in-a-highly-translational-preclinical/
/investors/press-releases/news-details/article/addex-adx71441-pharmacological-profile-published-in-neuropharmacology/
/investors/press-releases/news-details/article/addex-appoints-biopharmaceutical-industry-veteran-roger-g-mills-md-as-chief-medical-officer/
/investors/press-releases/news-details/article/addex-therapeutics-to-conduct-phase-iia-proof-of-concept-study-of-dipraglurant-in-focal-cervical-dy/
/investors/press-releases/news-details/article/addex-initiates-new-study-in-collaboration-with-us-national-institute-of-drug-abuse-with-adx88178-in/
/investors/press-releases/news-details/article/addex-therapeutics-reports-first-half-2016-operating-highlights-and-financial-results/
/investors/press-releases/news-details/article/addex-collaborators-published-new-data-supporting-the-role-of-negative-allosteric-modulators-of-foll/
/investors/press-releases/news-details/article/addex-adx71441-demonstrates-positive-results-in-highly-translational-preclinical-model-of-spasticity/
/investors/press-releases/news-details/article/lifesci-capital-issues-equity-research-report-on-addex-therapeutics/
/investors/press-releases/news-details/article/addex-shareholders-approved-all-board-proposals-at-2016-annual-general-meeting/
/investors/press-releases/news-details/article/addex-adx71441-demonstrates-positive-results-in-non-human-primate-model-of-cocaine-addiction/
/investors/press-releases/news-details/article/van-leeuwenhoeck-issues-research-note-on-addex-therapeutics/
/investors/press-releases/news-details/article/addex-annual-general-meeting-scheduled-for-23-june-2016/
/investors/press-releases/news-details/article/addex-dipraglurant-positive-phase-2-data-in-pd-lid-published-in-leading-peer-reviewed-journal-of-the/
/investors/press-releases/news-details/article/addex-increases-issued-share-capital-and-creates-treasury-shares/
/investors/press-releases/news-details/article/addex-therapeutics-reports-2015-financial-results/
/investors/press-releases/news-details/article/addex-reports-positive-results-of-an-mglu5-receptor-occupancy-study-with-dipraglurant-in-healthy-vol/
/investors/press-releases/news-details/article/addex-reports-successful-completion-of-an-mglu5-receptor-occupancy-study-with-dipraglurant-in-health/
/investors/press-releases/news-details/article/addex-dipraglurant-shows-highly-statistically-significant-anti-dyskinetic-effects-following-addition/
/investors/press-releases/news-details/article/addex-dipraglurant-receives-orphan-drug-designation-from-the-fda-for-levodopa-induced-dyskinesia/
/investors/press-releases/news-details/article/addex-reports-statistically-significant-positive-interim-data-for-dipraglurant-in-healthy-volunteer/
/investors/press-releases/news-details/article/addex-and-university-of-geneva-collaborators-awarded-swiss-grant-to-profile-addex-trkb-allosteric-mo/
/investors/press-releases/news-details/article/addex-scientists-publish-new-data-supporting-the-potential-of-mglu4-receptor-positive-allosteric-mod/
/investors/press-releases/news-details/article/addex-moves-rd-operations-to-genevas-campus-biotech/
/investors/press-releases/news-details/article/addex-adx71441-included-in-the-ninds-anticonvulsant-screening-program/
/investors/press-releases/news-details/article/addex-and-chuv-unil-collaborators-awarded-swiss-grant-to-advance-addex-mglur7-and-mglur4-allosteric/
/investors/press-releases/news-details/article/valuationlab-issues-research-report-on-addex-therapeutics-with-share-price-estimate-of-chf52-per-sh/
/investors/press-releases/news-details/article/addex-adx71441-demonstrates-robust-efficacy-in-multiple-preclinical-models-of-alcohol-use-disorde/
/investors/press-releases/news-details/article/addex-therapeutics-reports-first-half-2015-financial-results/
/investors/press-releases/news-details/article/addex-adx71149-demonstrates-synergistic-efficacy-with-levetiracetam-in-preclinical-models-of-epileps/
/investors/press-releases/news-details/article/pierre-fabre-pharmaceuticals-and-addex-therapeutics-sign-early-stage-agreement-in-the-central-nervou/
/investors/press-releases/news-details/article/alpha-deal-group-initiates-independent-research-coverage-on-addex-therapeutics/
/investors/press-releases/news-details/article/addex-dipraglurant-demonstrates-anxiolytic-and-antidepressant-like-activity-in-multiple-preclinical/
/investors/press-releases/news-details/article/valuationlab-issues-research-report-on-addex-therapeutics/
/investors/press-releases/news-details/article/addex-dipraglurant-dosed-in-first-subject-in-receptor-occupancy-study-in-collaboration-with-johns-ho/
/investors/press-releases/news-details/article/addex-shareholders-appoint-raymond-hill-and-tim-dyer-to-the-board-of-directors-and-approve-all-board/
/investors/press-releases/news-details/article/addex-identifies-new-potential-use-of-mglu7-receptor-nams-to-treat-stress-induced-visceral-pain/
/investors/press-releases/news-details/article/addex-and-prof-pisani-present-dipraglurant-data-in-rare-inherited-forms-of-dystonia/
/investors/press-releases/news-details/article/addex-annual-general-meeting-scheduled-for-11-june-2015/
/investors/press-releases/news-details/article/addex-enters-collaboration-with-prof-pisani-to-explore-the-therapeutic-use-of-dipraglurant-in-the-t/
/investors/press-releases/news-details/article/addex-therapeutics-reports-2014-financial-results/
/investors/press-releases/news-details/article/addex-raises-chf28-million-in-a-private-placement-and-extends-cash-runway-through-2017/
/investors/press-releases/news-details/article/addex-initiates-dipraglurant-receptor-occupancy-clinical-study-in-collaboration-with-johns-hopkins-u/
/investors/press-releases/news-details/article/addex-mglur2-nam-demonstrates-protection-in-preclinical-model-of-ischemic-neuronal-death/
/investors/press-releases/news-details/article/addex-completes-2014-with-strong-cash-position-and-provides-2015-strategic-update/
/investors/press-releases/news-details/article/addex-and-niaaa-enter-collaboration-to-evaluate-adx71441-in-alcohol-use-disorder/
/investors/press-releases/news-details/article/addex-amends-mglu2pam-collaboration-agreement-and-receives-usd757000/
/investors/press-releases/news-details/article/addex-and-the-charcot-marie-tooth-association-enter-collaboration-to-advance-adx71441-in-charcot-mar/
/investors/press-releases/news-details/article/addex-therapeutics-reports-first-half-2014-financial-results/
/investors/press-releases/news-details/article/addex-adx71441-positive-results-in-preclinical-model-of-nicotine-addiction/
/investors/press-releases/news-details/article/addex-shareholders-approve-all-board-proposals-at-annual-general-meeting-2/
/investors/press-releases/news-details/article/addex-therapeutics-publishes-annual-general-meeting-agenda/
/investors/press-releases/news-details/article/addex-therapeutics-publishes-annual-reports-2013/
/investors/press-releases/news-details/article/addex-therapeutics-reports-2013-financial-results/
/investors/press-releases/news-details/article/addex-reports-top-line-data-from-adx71149-phase-2a-study-in-patients-with-major-depressive-disorder/
/investors/press-releases/news-details/article/addex-and-nida-enter-collaboration-to-advance-adx71441-adx88178-in-drug-abuse-and-addiction/
/investors/press-releases/news-details/article/addex-licensee-completes-enrolment-of-120-patients-in-a-phase-2-clinical-trial-of-adx71149-for-the-t/
/investors/press-releases/news-details/article/addex-adx71441-dose-dependently-reduced-pmp22-expression-comparable-to-baclofen-in-a-pre-clinical-tr/
/investors/press-releases/news-details/article/addex-therapeutics-first-half-2013-financial-results/
/investors/press-releases/news-details/article/chronic-treatment-with-addex-dipraglurant-rescues-impairment-of-long-term-synaptic-plasticity-in-a-v/
/investors/press-releases/news-details/article/addex-therapeutics-raises-chf32-million-in-a-private-placement-to-international-institutional-inves/
/investors/press-releases/news-details/article/addex-completes-restructuring-to-focus-on-capturing-potential-upside-from-its-partnered-asset-and-ce/
/investors/press-releases/news-details/article/addex-announces-steps-to-capture-potential-upside-from-its-partnered-asset-and-preserve-value-for-sh/
/investors/press-releases/news-details/article/addex-validates-potential-efficacy-biomarker-for-phase-1-trial-of-its-gaba-b-positive-allosteric-mod/
/investors/press-releases/news-details/article/addex-reports-that-dipragluant-demonstrated-dose-dependent-mglu5-receptor-occupancy-in-a-non-human-p/
/investors/press-releases/news-details/article/addex-announces-cfo-tim-dyer-to-transition-to-external-consulting-role/
/investors/press-releases/news-details/article/addex-reports-adx71441-reduces-alcohol-intake-in-a-preclinical-model-of-chronic-alcohol-dependence/
/investors/press-releases/news-details/article/addex-receives-approval-to-initiate-a-phase-1-first-in-man-clinical-study-for-adx71441/
/investors/press-releases/news-details/article/addex-announces-issuance-of-a-broad-european-composition-of-matter-patent-for-dipraglurant/
/investors/press-releases/news-details/article/addex-dipraglurant-normalizes-striatal-cholinergic-dysfunction-in-a-validated-preclinical-model-of-p/
/investors/press-releases/news-details/article/addex-therapeutics-announces-presentation-of-dipraglurant-phase-2a-study-results-at-the-2013-annual/
/investors/press-releases/news-details/article/addex-shareholders-approve-all-board-proposals-at-annual-general-meeting-1/
/investors/press-releases/news-details/article/addex-therapeutics-awarded-1-mm-grant-from-the-michael-j-fox-foundation-for-parkinsons-research/
/investors/press-releases/news-details/article/addex-partners-with-viva-biotech-to-advance-allosteric-modulators-targeting-adenosine-2a-receptor/
/investors/press-releases/news-details/article/addex-therapeutics-reports-2012-financial-results/
/investors/press-releases/news-details/article/addex-to-focus-resources-on-clinical-pipeline/
/investors/press-releases/news-details/article/addex-dipraglurant-reduces-motor-abnormalities-in-a-preclinical-model-relevant-for-several-rare-type/
/investors/press-releases/news-details/article/addex-announces-issuance-of-a-broad-us-composition-of-matter-patent-for-adx71441/
/investors/press-releases/news-details/article/addex-announces-positive-data-with-adx71441-in-a-pre-clinical-transgenic-model-of-charcot-marie-toot/
/fileadmin/user_upload/Media_Exposure/biopharmadealmakers.pdf
/investors/press-releases/news-details/article/addex-reports-top-line-data-from-a-successful-phase-2a-clinical-study-with-adx71149-in-schizophrenia/
/investors/press-releases/news-details/article/addex-reports-adx71441-reduces-alcohol-intake-in-a-preclinical-model-of-alcohol-binge-drinking/
/investors/press-releases/news-details/article/addex-updates-financial-guidance-for-2012/
/investors/press-releases/news-details/article/addex-therapeutics-raises-10-million-in-a-private-placement-to-international-institutional-investor/
/investors/press-releases/news-details/article/addex-and-collaborators-awarded-swiss-cti-grant-to-develop-allosteric-modulators-for-neurodegenerati/
/investors/press-releases/news-details/article/addex-mglur4-allosteric-modulator-effective-in-multiple-sclerosis-model/
/fileadmin/user_upload/Media_Exposure/2012.09.18_L_Agefi_Addex.pdf
/investors/press-releases/news-details/article/addex-partner-doses-first-patient-in-phase-2-clinical-study-of-adx71149-for-the-treatment-of-major-d/
/investors/press-releases/news-details/article/addex-therapeutics-first-half-2012-financial-results/
/investors/press-releases/news-details/article/addex-therapeutics-first-half-2012-financial-results-next-wednesday/
/fileadmin/user_upload/Media_Exposure/PSD_14120322004.pdf
/investors/press-releases/news-details/article/addex-announces-the-publication-of-positive-data-on-the-efficacy-of-mglur4-positive-allosteric-modul/
/investors/press-releases/news-details/article/addex-to-present-phase-2a-dipraglurant-data-at-movement-disorder-societys-international-congress/
/investors/press-releases/news-details/article/addex-partner-to-initiate-phase-2-clinical-trial-of-adx71149-for-the-treatment-of-major-depressive-d/
/contact/
/sitemap/

Possible email addresses for addextherapeutics.com

info@addextherapeutics.com
email@addextherapeutics.com
support@addextherapeutics.com
contact@addextherapeutics.com
admin@addextherapeutics.com
postmaster@addextherapeutics.com
hostmaster@addextherapeutics.com
domain@addextherapeutics.com
abuse@addextherapeutics.com

Possible Domain Typos

www.ddextherapeutics.com, www.aqddextherapeutics.com, www.qddextherapeutics.com, www.awddextherapeutics.com, www.wddextherapeutics.com, www.azddextherapeutics.com, www.zddextherapeutics.com, www.axddextherapeutics.com, www.xddextherapeutics.com, www.asddextherapeutics.com, www.sddextherapeutics.com, www.adextherapeutics.com, www.adxdextherapeutics.com, www.axdextherapeutics.com, www.adsdextherapeutics.com, www.asdextherapeutics.com, www.adwdextherapeutics.com, www.awdextherapeutics.com, www.adedextherapeutics.com, www.aedextherapeutics.com, www.adrdextherapeutics.com, www.ardextherapeutics.com, www.adfdextherapeutics.com, www.afdextherapeutics.com, www.advdextherapeutics.com, www.avdextherapeutics.com, www.adcdextherapeutics.com, www.acdextherapeutics.com, www.adextherapeutics.com, www.addxextherapeutics.com, www.adxextherapeutics.com, www.addwextherapeutics.com, www.adwextherapeutics.com, www.addeextherapeutics.com, www.adeextherapeutics.com, www.addrextherapeutics.com, www.adrextherapeutics.com, www.addfextherapeutics.com, www.adfextherapeutics.com, www.addvextherapeutics.com, www.advextherapeutics.com, www.addcextherapeutics.com, www.adcextherapeutics.com, www.addxtherapeutics.com, www.addewxtherapeutics.com, www.addwxtherapeutics.com, www.addesxtherapeutics.com, www.addsxtherapeutics.com, www.addedxtherapeutics.com, www.adddxtherapeutics.com, www.addefxtherapeutics.com, www.addfxtherapeutics.com, www.adderxtherapeutics.com, www.addrxtherapeutics.com, www.adde3xtherapeutics.com, www.add3xtherapeutics.com, www.adde4xtherapeutics.com, www.add4xtherapeutics.com, www.addetherapeutics.com, www.addexztherapeutics.com, www.addeztherapeutics.com, www.addexatherapeutics.com, www.addeatherapeutics.com, www.addexstherapeutics.com, www.addestherapeutics.com, www.addexdtherapeutics.com, www.addedtherapeutics.com, www.addexctherapeutics.com, www.addectherapeutics.com, www.addex therapeutics.com, www.adde therapeutics.com, www.addexherapeutics.com, www.addextrherapeutics.com, www.addexrherapeutics.com, www.addextfherapeutics.com, www.addexfherapeutics.com, www.addextgherapeutics.com, www.addexgherapeutics.com, www.addexthherapeutics.com, www.addexhherapeutics.com, www.addextyherapeutics.com, www.addexyherapeutics.com, www.addext5herapeutics.com, www.addex5herapeutics.com, www.addext6herapeutics.com, www.addex6herapeutics.com, www.addexterapeutics.com, www.addexthberapeutics.com, www.addextberapeutics.com, www.addexthgerapeutics.com, www.addextgerapeutics.com, www.addexthterapeutics.com, www.addextterapeutics.com, www.addexthyerapeutics.com, www.addextyerapeutics.com, www.addexthuerapeutics.com, www.addextuerapeutics.com, www.addexthjerapeutics.com, www.addextjerapeutics.com, www.addexthmerapeutics.com, www.addextmerapeutics.com, www.addexthnerapeutics.com, www.addextnerapeutics.com, www.addexthrapeutics.com, www.addexthewrapeutics.com, www.addexthwrapeutics.com, www.addexthesrapeutics.com, www.addexthsrapeutics.com, www.addexthedrapeutics.com, www.addexthdrapeutics.com, www.addexthefrapeutics.com, www.addexthfrapeutics.com, www.addextherrapeutics.com, www.addexthrrapeutics.com, www.addexthe3rapeutics.com, www.addexth3rapeutics.com, www.addexthe4rapeutics.com, www.addexth4rapeutics.com, www.addextheapeutics.com, www.addexthereapeutics.com, www.addextheeapeutics.com, www.addextherdapeutics.com, www.addexthedapeutics.com, www.addextherfapeutics.com, www.addexthefapeutics.com, www.addexthergapeutics.com, www.addexthegapeutics.com, www.addexther4,apeutics.com, www.addexthe4,apeutics.com, www.addexthertapeutics.com, www.addexthetapeutics.com, www.addexther5apeutics.com, www.addexthe5apeutics.com, www.addextherpeutics.com, www.addextheraqpeutics.com, www.addextherqpeutics.com, www.addextherawpeutics.com, www.addextherwpeutics.com, www.addextherazpeutics.com, www.addextherzpeutics.com, www.addextheraxpeutics.com, www.addextherxpeutics.com, www.addextheraspeutics.com, www.addextherspeutics.com, www.addextheraeutics.com, www.addextherapoeutics.com, www.addextheraoeutics.com, www.addextherapleutics.com, www.addextheraleutics.com, www.addextherap0eutics.com, www.addexthera0eutics.com, www.addextherap-eutics.com, www.addexthera-eutics.com, www.addextherap_eutics.com, www.addexthera_eutics.com, www.addextheraputics.com, www.addextherapewutics.com, www.addextherapwutics.com, www.addextherapesutics.com, www.addextherapsutics.com, www.addextherapedutics.com, www.addextherapdutics.com, www.addextherapefutics.com, www.addextherapfutics.com, www.addextheraperutics.com, www.addextheraprutics.com, www.addextherape3utics.com, www.addextherap3utics.com, www.addextherape4utics.com, www.addextherap4utics.com,

More Sites

Amelia Kahaney

Author site

Number of used Technologies: 3
Number of used Javascript files: 3
Server Location: United States / - 198.49.23.145
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, Lightbox, Php (Hypertext Preprocessor), SVG (Scalable Vector Graphics)

上海艾薇儿生物科技有限公司

Number of used Technologies: 3
Number of used Javascript files: 3
Server Software: Microsoft-IIS/7.5
Server Location: China / Hangzhou - 60.205.43.122
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Iframe, Javascript

Cori Schwabe

Number of used Technologies: 4
Number of used Javascript files: 4
Server Location: United States / - 198.185.159.145
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, Lightbox, Php (Hypertext Preprocessor), SVG (Scalable Vector Graphics)

Cambridge Youth Soccer - Home

Number of used Technologies: 8
Number of used Javascript files: 8
Server Location: United States / Houston - 108.167.135.72
List of used Technologies: CSS (Cascading Style Sheets), Google Font API, Html (HyperText Markup Language), Html5, Javascript

The Manifold | Automanic obsession

Automanic obsession

Number of used Technologies: 9
Number of used Javascript files: 9
Server Software: nginx
Server Location: United States / San Francisco - 192.0.78.25
List of used Technologies: Wordpress CMS, CSS (Cascading Style Sheets), Google Font API, Gravatar, Html (HyperText Markup Language), Html5, Javascript, Php (Hypertext Preprocessor), Pingback, SVG (Scalable Vector Graphics), Twitter Button

福岡県立小倉高等学校　明陵同窓会　公式ホームページ

福岡県立小倉高等学校の同窓会　明陵同窓会の公式ページです。

Number of used Technologies: 6
Number of used Javascript files: 6
Server Software: A p a c h e
Server Location: Japan / - 203.183.202.206
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Php (Hypertext Preprocessor)

Utensileria elettrica - Firenze - Ferramenta FPV

Ferramenta FPV di Firenze è un'azienda leader nella vendita di prodotti di ferramenta; dall'utensileria elettrica, fino alle calzature antinfortunistiche.

Number of used Technologies: 43
Number of used Javascript files: 43
Server Software: Apache-Coyote/1.1
Server Location: Italy / Milan - 212.48.12.143
List of used Technologies: SiteCatalyst, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Html5, Javascript, jQuery Cookie, jQuery Fancybox, jQuery UI, Php (Hypertext Preprocessor)

湖南鑫众工业装备有限责任公司

Number of used Technologies: 4
Number of used Javascript files: 4
Server Software: Microsoft-IIS/6.0
Server Location: China / Zhengzhou - 122.114.225.141
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript, Swf Object

Welcome to PUREFOODSGLYCEMIC.COM

Number of used Technologies: 3
Number of used Javascript files: 3
Server Software: Microsoft-IIS/7.5
Server Location: United States / Scottsdale - 184.168.221.96
List of used Technologies: Google Adsense, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Javascript

REBECCA SOL, Interpret-Künstlerin der Genre Musical, Pop-Rock und Klassik

Interpret-Künstlerin der Genre Musical, Pop-Rock und Klassik

Number of used Technologies: 0
Number of used Javascript files: 0
Server Software: Apache
Server Location: Germany / - 62.144.163.44
List of used Technologies: CSS (Cascading Style Sheets), Html (HyperText Markup Language)

Addextherapeutics.com